HomeBIOTECHNOLOGY
BIOTECHNOLOGY
Medical Device News Magazine reports breaking biotechnology news in addition to medical device news.
Shuttle Pharmaceuticals Provides First Quarter 2023 Corporate Update
Shuttle Pharmaceuticals was founded in 2012 by faculty members of the Georgetown University Medical Center, Shuttle Pharma is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes for cancer patients treated with radiation therapy (RT).
Novavax’s Nuvaxovid ™ Receives Positive CHMP Opinion for Full Marketing Authorization for the Prevention of COVID in the EU
Nuvaxovid NVX-CoV2373 is a protein-based vaccine made by creating copies of the surface spike protein of SARS-CoV-2 that causes COVID.
The Use Of Immunoassay Reagents In Healthcare: Benefits And Applications
Immunoassays are biochemical tests designed to determine the presence and concentration of a particular micro or macro molecule or chemical, often in a solution...
Vios Fertility Institute – St. Louis and TMRW Life Sciences Launches State-of-the-Art Cryo Management Technology for Fertility Specimens
TMRW’s technology provides the world’s first and only fully automated specimen management platform (CryoRobot) that identifies, tracks, and manages frozen eggs and embryos - central to almost every IVF journey. Vios Fertility Institute’s Chicago lab was the first in the world to adopt this revolutionary technology in early 2021.
Bioretec Files for CE Mark for its Bioresorbable RemeOs Magnesium Screw in the EU
Bioretec’s target is to receive the CE mark and to introduce the bioresorbable magnesium alloy trauma screw into the markets in the European Union during 2022.
Omeros Completes Sale of OMIDRIA® Franchise to Rayner Surgical
Omeros received approximately $126 million in cash at closing. In addition, Omeros retains and is entitled to collect the full amount of its accounts receivable outstanding as of today’s closing.
Curocell, Breaks Ground on ‘CAR-T Manufacturing GMP Facility’
The GMP Facility for commercial manufacturing CAR-T Cell therapy and R&D Center for further pipeline development are constituting the 17,325 square-meter site of CAR-T Center.
Neoss Launches NeoGenix XP™
This exciting product line will add new dimensions to Neoss existing Bone Regeneration offering, providing an enhanced offering of Bone materials and membranes.
USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases
USMI & JCRI have developed a Humidified Electrical Reactive Oxygen System (The Canady Helios™ Cold Plasma HERO™ System) which generates an ionized cold plasma mixed with the Air/O2 from oxygen sources such as hospital ventilators, CPAPs (Continuous Positive Airway Pressure), BIPAPs (Bilevel Positive Airway Pressure) or O2 face masks.